Loading the company…
Loading the company…
㈜에이치비티
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Chungbuk, founded in 2020. Industry: Chemicals & Materials. Revenue for 2025 was ₩7.0bn. It has 61 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2022-06-29 · latest registration 2022-10-07 · newest first
본 발명은 심리스 캡슐(seamless capsule)용 피막액 조성물에 있어서, 상기 피막액 조성물은, 총 중량에 있어서, 카라기난 2.0중량%~5.0중량%, 글리세린 1.0중량%~3.0중량%, 알긴산나트륨 0.5중량%~2.0중량%, 아미노산 혼합물 1.0중량%~4.0중량%, 색소 0.01중량%~0.03중량%, 정제수 85.97중량%~95.49중량%로 이루어지는 피막액 조성물을 이용하여 피막액을 제조하는 피막액 제조단계; 상기 피막액과 향료를 동시에 공급받아 계면장력에 의해 심리스 캡슐(seamless capsule)을 제조하는 캡슐 제조단계; 제조된 심리스 캡슐을 MCT 오일(Medium-Chain Triglyceride oil)로 냉각하는 냉각단계; 냉각된 심리스 캡슐을 건조시키는 건조단계; 건조된 심리스 캡슐의 표면에 잔존하는 MCT 오일을 제거하는 세척단계; 세척된 심리스 캡슐의 불량 유무를 판단 및 선별하는 선별단계;를 포함하는 아미노산 혼합물을 포함하는 심리스 캡슐 제조 방법을 제공하는 것을 특징으로 한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 8.0 | 7.0 |
| Cost of sales | 7.7 | 6.8 |
| Gross profit (loss) | 0.3 | 0.2 |
| Selling, general and administrative expenses | 0.8 | 1.2 |
| Operating income (loss) | (0.4) | (1.0) |
| Non-operating income | 0.0 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.0 | 0.1 |
| Non-operating expenses | 0.9 | 0.6 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.7 | 0.6 |
| Other | 0.3 | 0.0 |
| Profit (loss) before tax | (1.3) | (1.5) |
| Net income (loss) | (1.3) | (1.5) |
Revenue ₩7bn, down 12.6% YoY.
Operating margin -14.6% (prior -5.3%).
Net income ₩-1.5bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-08